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a  b  s  t  r  a  c  t
Guavira  fruits  have  antimicrobial,  antioxidant,  antinociceptive,  and  anti-inﬂammatory  activities.  Spray
drying has  been  widely  used  in  the food  industry  presenting  good  retention  in  bioactive  compounds  used
to  transform  the  pulp/fruit  juice  into  powder  form.  Therefore,  the  present  study  has  evaluated  the  anti-
inﬂammatory  and  antinociceptive  activities  of the  microencapsulated  pulp  of  Campomanesia  adamantium
(Cambess.)  O.Berg,  Myrtaceae,  by  spray  drying.  Different  groups  of  mice  were  treated  with  the doses  of
100 and  300  mg/kg  of microencapsulated  “guavira”  pulp  and  inﬂammatory  parameters  were  assessed  in
a carrageenan  paw  edema-model  and leukocyte  migration  with  pleurisy  model,  while  the  antinocicep-
tive  activity  was  assessed  using  the  formalin  method  and  CFA-induced  hyperalgesia  model.  A  signiﬁcant
reduction  in  leukocyte  migration  and  in  paw edema  was  observed  in  rodents  in  all  time  after  carrageenan
injection  for both  doses  of  microencapsulated  pulp  of  C.  adamantium  when  compared  with control  group.
Microencapsulated  pulp  of  C.  adamantium  also  reduced  licking  time  at the  ﬁrst  (nociceptive)  and  sec-
ond  (inﬂammatory)  phases  in the formalin  model.  In CFA-induced  cold  and  mechanical  hyperalgesia,
depressive  behavior,  and  knee  edema,  all parameters  analyzed  were  signiﬁcantly  inhibited  by  microen-
capsulated  pulp  of  C.  adamantium.  Microencapsulation  by  spray  drying  proved  to  be a technique  that
promotes  bioavailability  and  the  preservation  of  bioactive  components  in  guavira  pulp.
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he  CC© 2016  Sociedade  B
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ntroduction
Among the Brazilian Cerrado, there is a native plant species
nown as Campomanesia adamantium (Cambess.) O.Berg, Myr-
aceae, (guavira) (Lorenzi, 2000) that is widely found in isolated
elds in Midwestern and southeastern Brazil. The fruits grow on
mall bushes and have speciﬁc characteristics, such as bright col-
rs from green to yellow, with a strong and citric aroma (Fernandes
t al., 2014). Its fruit has the potential to be used in natura in the
ood industry and as ﬂavoring in the drink industry due to its juici-
ess, mineral content, ﬁber, and interesting bioactive substancesPlease cite this article in press as: Viscardi, D.Z., et al. Anti-inﬂamma
microencapsulated pulp. Revista Brasileira de Farmacognosia (2016), 
rom the nutritional and functional points of view as phenolic com-
ounds. In addition to their pleasant taste, the fruits are considered
 source of vitamin C (Breda et al., 2012), which is an important
∗ Corresponding author.
E-mail: danieliviscardi@ufgd.edu.br (D.Z. Viscardi).
http://dx.doi.org/10.1016/j.bjp.2016.09.007
102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Edit
reativecommons.org/licenses/by-nc-nd/4.0/).eira  de Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This  is  an open
 BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
micronutrient involved in several biological functions in the human
body (Pascoal et al., 2014).
In folk medicine “guavira” fruits are used as antirheumatic,
antidiarrheal, hypocholesterolemic, anti-inﬂammatory (Ramos
et al., 2007), and to the treatment of cystitis and urethritis (Pascoal
et al., 2014). Previous studies with the fruits have observed antimi-
crobial (Pavan et al., 2009; Cardoso et al., 2010), antioxidant
(Coutinho et al., 2010), antinociceptive, and anti-inﬂammatory
activities (Ferreira et al., 2013), as well as apoptotic and antiprolifer-
ative activities in PC-3 human prostate carcinoma cells (Fernandes
et al., 2014). Phytochemical investigations have found the pres-
ence of ﬂavanones and chalcones in the ethyl acetate extract from
its fruits (Pavan et al., 2009) and phenolic contents in the ethyl
acetate, ethanol, and hexane extracts from the leaves, particu-tory, and antinociceptive effects of Campomanesia adamantium
http://dx.doi.org/10.1016/j.bjp.2016.09.007
larly ﬂavonoids (Coutinho et al., 2010). Ferreira et al. (2013) has
demonstrated the presence of myricitrin, quercetin, and myricetin
in ethyl acetate in the extract from the leaves of C. adaman-
tium. The hydro-alcoholic extract of C. adamantium fruit peels has
ora Ltda. This is an open access article under the CC BY-NC-ND license (http://
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nti-inﬂammatory, antihyperalgesic, and antidepressant activities
n rodents (Souza et al., 2014).
The fruits of C. adamantium are restricted to the period
f harvesting (Coutinho et al., 2008). Conservation alternatives
o improve the availability of pulp, such as spray drying, has
een widely used in the food industry (Tonon et al., 2009,
013) presenting good retention in bioactive compounds used
o transform the pulp/fruit juice into powder form (Chen
t al., 2014), allowing prolonged storage and greater sta-
ility of the product, giving it a longer shelf life (Souza
t al., 2014; Mahdavi et al., 2014). Together with this idea,
ecent technological advances, such as the microencapsulation
echnique, have helped to solve these issues and renewed
nterest in natural products in drug discovery (Lescano et al.,
014).
Phenolic compounds, particularly ﬂavonoids, have free-radical
cavenging properties and also inhibit lipid peroxidation. The pres-
nce of ﬂavonoids and chalcones in the human diet can reduce the
isk of cancers and tumors and also exhibit several activities, such as
ntibacterial, antifungal, anti-inﬂammatory, antileishmanial, anti-
alarial, and anti-HIV protease (Hodek et al., 2012; Tewtrakul et al.,
003; Djeridane et al., 2006; Cabrera et al., 2007; Nowakowska,
007).
Therefore, the study of microcapsuled fruits of C. adamantium
nables scientiﬁc knowledge of the pharmacological properties
f the plant, considering that there may  be loss of bioac-
ive compounds and the microencapsulation technique promotes
ts preservation. Thus, this study aims to evaluate the anti-
nﬂammatory parameters and antinociceptive effects of the
icroencapsulated pulp of C. adamantium (MPCA) in rodents.
aterials and methods
lant material
Fruits of Campomanesia adamantium (Cambess.) O.Berg, Myr-
aceae, were collected at “Cerrado,” Brazil, on November 2014. A
oucher specimen was deposited in the herbarium of the Faculty
f Biological Sciences of UFGD (DDMS 4602). Fruits were sanitized
nd the pulp, peel, and seeds were separated. The pulp was  packed
n rigid polypropylene containers and stored at −18 ◦C until use.
igh-performance liquid chromatography (HPLC)
The solvents employed were methanol (HPLC grade, Tedia
ompany, Fairﬁeld, OH, USA) and acetonitrile (HPLC grade, Tedia
ompany, Fairﬁeld, OH, USA). Samples of the pulp of C. adaman-
ium were prepared with 1 g of pulp extract dissolved in 5 ml  of
ethanol in an ultrasound for 20 min. Samples of MPCA were pre-
ared with 5 g of microcapsules that were extracted with 25 ml  of
ethanol in an ultrasound for 20 min  and the dried material into a
hapel was reconstructed in 5 ml  of methanol.
The samples and standards were analyzed using an analytical
PLC (Varian 210) system, with a ternary solvent delivery system
nd an autosampler. A photodiode array detector was  monitored
t  = 200–800 nm.  The HPLC column was C-18 (25 cm × 4.6 mm;
article size, 5 m;  Luna, Phenomenex, Torrance, CA, USA), with
 small pre-column (2.5 cm × 3 mm)  containing the same pack-
ng to protect the analytical column. The ﬂow rate and injected
olume were 1.0 ml  min−1 and 20 l, respectively. All chromato-
raphic analyses were performed at 22 ◦C.Please cite this article in press as: Viscardi, D.Z., et al. Anti-inﬂamma
microencapsulated pulp. Revista Brasileira de Farmacognosia (2016), 
The elution was conducted using in 0 min, acetonitrile 12%,
ater 50%, and methanol 38%; in 40 min, acetonitrile 10%, water
0%, and methanol 80%; and in 45 min, returning to the initial con-
ition. PRESS
armacognosia xxx (2016) xxx–xxx
The substances used in HPLC analysis were isolated from the
leaves of C. adamantium. Compounds were puriﬁed by HPLC, result-
ing in purity between 86% and 96%. The substances were dissolved
separately in methanol to a concentration of 10 g/ml degree chro-
matographic preparation of stock solutions used in the analysis by
HPLC. The standards were easily identiﬁed by their UV absorption
spectra and retention times. The substances found in the extracts
were unambiguously identiﬁed by performing coinjection experi-
ments in which aliquots of samples and standards were mixed and
diluted to a known volume and analyzed by HPLC.
Microcapsulation of Campomanesia adamantium fruits
After preliminary tests and through other studies described in
the literature, microcapsules were produced using maltodextrin 8%
(DE 20 Maltogill, Cargill, Uberlândia, Brazil), gum Arabic 8% (Synth,
Brazil), and chitosan 8% (Purifarma, São Paulo, Brazil) purchased
from JKLAB (Química Diagnóstica e Seguranc¸ a Ltda) (Oliveira et al.,
2014). Samples were prepared using 24% encapsulating agent, 16%
distilled water, and 60% pulp. The mixture of each formulation was
homogenized in an Ultra-Turrax at a speed of 18,000 rpm until com-
plete dissolution of the carrier agent, obtaining samples comprising
30% solids (encapsulating agent and pulp). The atomization pro-
cess was conducted in a concurrent ﬂow pattern using a mini spray
dryer – LM (model MSD  1.0 LABMAQ). Samples were fed into the
atomizer at a ﬂow rate of 0.5 l h−1 with a 1.2 mm nozzle diameter,
air ﬂow of 35 l min−1, and a drying air temperature of 180 ◦C. The
determination of moisture content and ascorbic acid (AOAC, 2000)
were performed on fresh and microencapsulated pulp of guavira.
Experimental animals
Male and female Swiss mice (20–25 g) were obtained from Uni-
versidade Federal da Grande Dourados (UFGD) biotherium. The
animals were kept in collective cages under controlled temper-
ature (23 ± 1 ◦C) and light conditions (12-h light/dark cycle), and
had access to food and water ad libitum.  The 23/2014 protocol was
approved by the Ethics Committee on Animal Use (CEUA/UFGD).
Pleurisy
Different groups of female Swiss mice (n = 5 animals/group)
were orally treated with MPCA at doses of 100 and 300 mg/kg or
vehicle (0.9% saline solution, also called the control group). The
positive control group received dexamethasone subcutaneously at
a dose of 1 mg/kg. Pleurisy was induced in experimental groups by
intrapleural injection of 100 l of 1% carrageenan diluted in saline,
after 1 h of treatment, as previously described (Velo et al., 1973). The
naive group received 100 l of sterile saline by intrapleural injec-
tion. After 4 h, animals were euthanized and the pleural cavity was
washed with 1 ml  phosphate-buffered saline. An aliquot of 20 l of
lavage (exudate) was  collected from the pleural cavity, and diluted
with Turck solution (1:20) and used for total leukocyte count in a
Neubauer chamber (Kassuya et al., 2009).
Formalin-induced nociception
Sixty min  before formalin injection, male Swiss mice (n = 6 ani-
mals/group) were divided into groups: dexamethasone (1 mg/kg,
subcutaneous route), MPCA (100 and 300 mg/kg, oral route), and
vehicle (saline solution, 0.9%, oral route). After respective treat-tory, and antinociceptive effects of Campomanesia adamantium
http://dx.doi.org/10.1016/j.bjp.2016.09.007
ment, 20 l of saline containing 2.5% of formalin was  injected in
the right hind paw. Nociceptive response (paw licking) in seconds
was evaluated from 0 to 5 min  (phase 1 – neurogenic pain) and from
15 to 30 min  (phase 2 – inﬂammatory response) after injection of
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Fig. 1. Chromatogram of the pulp and microcapsules of Campomanesia adamantium
obtained by HPLC. Identiﬁed substances: 3,5,7,3′ ,4′ ,5′-hexahydroxy-ﬂavonol
(peak 1), 3,5,7,3′ ,4′ ,5′-hexahydroxy-ﬂavonol-3-O--l-arabinofuranoside (Peak
2),  3,5,7,3′ ,4′ ,5′-hexahydroxy-ﬂavonol-3-O--l-raminopyranoside (peak 3), 7-
Analyses by high-performance liquid chromatography in
the pulp and the C. adamantium microcapsules identiﬁed the
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Fig. 2. Effect of oral administration of the pulp and microcapsules of Campomanesia
adamantium on the inhibition of the leukocyte migration at both doses tested on
pleurisy test. Mice were treated 1 h before an intrapleural injection of carrageenan,
with microcapsules (100 or 300 mg/kg), dexamethasone (DEXA, 1 mg/kg, s.c.), orARTICLEJP-322; No. of Pages 8
D.Z. Viscardi et al. / Revista Brasileir
ormalin in the paw (Kassuya et al., 2009). After that, animals were
ubmitted to cold sensitivity, paw edema measurement.
pen ﬁeld test
Fifty minutes after oral treatment with MPCA (100 and
00 mg/kg) or vehicle (saline solution, 0.9%, oral route), the mice
ere placed individually in the center of the arena, and the behav-
or was quantiﬁed for 5 min. The number of “squares” invaded
ambulation) in the center and the periphery of the arena were ana-
yzed. Ambulation was used to evaluate the horizontal movement
Piccinelli et al., 2015).
arrageenan-induced paw edema
Different groups of male Swiss mice (n = 5 animals/group) were
rally treated with MPCA (100 and 300 mg/kg), or vehicle (control
roup). Another group was treated subcutaneously with dexameth-
sone (1 mg/kg). After 1 h, animals received a solution of 50 l
arrageenan injection (300 g/paw) in the left hind paw. The other
aw received the same volume of sterile saline 0.9%. The paw vol-
me  was measured at 1, 2, 3, and 4 h after carrageenan injection
ith a plethysmometer. The results were expressed as the differ-
nce between the left and right paws at each time (Kassuya et al.,
009).
FA-induced paw inﬂammation, cold and mechanical
yperalgesia, and depression
Animals were subjected to induction of peripheral inﬂam-
ation by administration of 20 l of CFA (Freund’s Complete
djuvant) into the right paw. For 10 days after CFA, different
roups of male Swiss mice (n = 6/group) were orally treated with
PCA (100 mg/kg). Basal values of mechanical sensitivity were
etermined before CFA injection. Paw edema was performed as pre-
iously described at 1, 2 and 4 h on the ﬁrst day and once per day
or 10 days. In addition, response to acetone (sensitivity to cold),
ail suspension (to analyze depression), and knee edema were also
erformed.
Cold hyperalgesia was measured by the acetone test as
escribed previously (25). A needle connected to a syringe was used
o drop 30 l of acetone on the paw and the duration (in seconds) of
he paw withdrawal was recorded. Minimal and maximal cut-offs
ere assigned at 0.5 s and 20 s, respectively. Paw withdrawal due
o locomotion or weight shifting were not counted and such trials
ere repeated (Ferreira et al., 2013).
Mechanical sensitivity was measured with Electronic analges-
meter (Aquino et al., 2015) at 0 (basal values), 1, 2, and 4 h after
he injection on the ﬁrst day and once per day for 10 days. Oral
reatment was administered daily for 10 days after CFA injection.
Thickness paw edema was assessed using a plethysmometer
0 min  before any treatment and after 1 h of formalin injection.
he results were expressed in microliters as the difference between
he baseline and post-injection edema values, with modiﬁcations
f Kassuya et al. (2009). On the 10th day after CFA injection, assess-
ent of knee edema was  performed in mice, using a micrometer.
Tail suspension test is a depression model that assesses immo-
ility of mice. Mice were individually suspended on an acrylic box
ith their tails attached with tape. The behavior was  ﬁlmed for
 min  and the duration of immobility was measured in seconds.
tatistical analysesPlease cite this article in press as: Viscardi, D.Z., et al. Anti-inﬂamma
microencapsulated pulp. Revista Brasileira de Farmacognosia (2016), 
The results are expressed as mean ± standard error of the mean.
or comparison of results between experimental groups, analysis
f variance (one-way and two-way ANOVA) was used, followeddihydroxy-5-metoxiﬂavanone (peak 4), 6-methyl-7-hydroxy-5-metoxiﬂavanone
(peak 5), 2′ ,4′-dihydroxy-6′-metoxichalcone (peak 6), and 2′ ,4′-dihydroxy-5′-
methyl-6′-metoxichalcone (peak 7).
by the Newman–Keuls or Bonferroni test. The number of animals
per group is indicated in the legends. Statistical differences were
considered signiﬁcant at p < 0.05. Asterisk (*) or (#) denotes a sig-
niﬁcant difference between groups.
Resultstory, and antinociceptive effects of Campomanesia adamantium
http://dx.doi.org/10.1016/j.bjp.2016.09.007
saline solution (vehicle). Naive group, also treated with saline, received an intrapleu-
ral injection of sterile saline. Each bar represents the mean ± SEM of ﬁve animals.
*p  < 0.001 when compared to control group. Differences between groups were ana-
lyzed by analysis of variance (one-way ANOVA) followed by the Newman–Keuls.
test.
Please cite this article in press as: Viscardi, D.Z., et al. Anti-inﬂammatory, and antinociceptive effects of Campomanesia adamantium
microencapsulated pulp. Revista Brasileira de Farmacognosia (2016), http://dx.doi.org/10.1016/j.bjp.2016.09.007
ARTICLE IN PRESSG ModelBJP-322; No. of Pages 8
4 D.Z. Viscardi et al. / Revista Brasileira de Farmacognosia xxx (2016) xxx–xxx
0
50
100
150
Vehicle
Microcapsu les Dexa
1300100 mg/kg
Formalin phase  IA
*
*
*
Se
co
nd
s
0
100
200
300
400
Vehicle
Microcapsu les Dexa
1300100 mg/kg
Formalin phase  IIB
*
*
*
Se
co
nd
s
0.0
0.2
0.4
0.6
0.8
Vehicle
Microcap sules Dexa
1300100  mg/kg
C
**
**
**
Paw oedema
Pa
w
 o
ed
em
a 
(m
l)
0
5
10
15
20 Cold sensitivity
Vehicle
Microcapsu les Dexa
1300100 mg/kg
***
***
***
D
Se
co
nd
s
Fig. 3. Effect of the pulp and microcapsules of Campomanesia adamantium on formalin-induced paw licking or biting in mice and on formalin-induced cold sensitivity and
edema  induced by formalin. (A, B) The essential oil of microcapsules at doses of 100 and 300 mg/kg presented antinociceptive effects in phase I and II test. (C) Edema induced
by  formalin. (D) Effect of the MPCAon cold sensitivity after treatment with microcapsules cold sensitivity with acetone in mice. Each bar represents the mean ± SEM of six
animals. *p < 0.001 when compared to the control group. Differences between groups were analyzed by analysis of variance (one-way ANOVA) followed by the Newman–Keuls
test.
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Fig. 4. Effect of the pulp and microcapsules of Campomanesia adamantium in carrageenan-induced paw edema in mice. Animals received microcapsules (100 or 300 mg/kg,
p.o.)  or control (vehicle) or dexamethasone (DEXA, 1 mg/kg, s.c.) and after 1 h, an intraplantar injection of carrageenan (300 g/paw). Graphics (A), (B), (C), and (D) represent
the  evaluation of paw edema after 1, 2, 3, and 4 h, respectively, after carrageenan injection. Each bar represents the mean ± SEM of ﬁve animals. *p < 0.05, **p < 0.001 when
compared with the control group. Differences between groups were analyzed by analysis of variance (one-way ANOVA) followed by the Newman–Keuls test.
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Fig. 5. Effect of the oral administration of microencapsulated pulp of Campomanesia
adamantium (MPCA) (100 mg/kg) on mechanical hyperalgesia and paw edema in
mice. (A) Animals received the MPCA (10 m and 300 mg/kg, p.o.) or vehicle, and
after 1 h, 20 l of CFA (Freund’s Complete Adjuvant) injection in the right hind paw.
Mechanical sensitivity was measured with von Frey analgesimeter at 1, 2, and 4
after the injection on the ﬁrst day and (B) once a day for 10 days. (C) Effect of oral
administration of MPCAon CFA-induced paw edema. Paw edema was performed as
previously described once a day during 10 days. Each bar represents the mean ± SEMARTICLEJP-322; No. of Pages 8
D.Z. Viscardi et al. / Revista Brasileir
ubstances: 3,5,7,3′,4′,5′-hexahydroxy-ﬂavonol (peak 1), 3,5,7,3′,4′,
′-hexahydroxy-ﬂavonol-3-O--l-arabinofuranoside (peak 2), 3,5,
,3′,4′,5′-hexahydroxy-ﬂavonol-3-O--l-raminopyranoside (peak
), 7-dihydroxy-5-metoxiﬂavanone (peak 4), 6-methyl-7-hydroxy-
-metoxiﬂavanone (peak 5), 2′,4′-dihydroxy-6′-metoxichalcone
peak 6), and 2′,4′-dihydroxy-5′-methyl-6′-metoxichalcone (peak
) (Fig. 1).
PCA prevented migration of leukocytes to the pleural cavity
nduced by carrageenan
The oral administration of C. adamantium microencapsulated
ulp signiﬁcantly inhibited the leukocyte migration at all doses
ested (100 and 300 mg/kg), being greater at dose of 100 mg/kg with
aximal inhibition of 50 ± 4% compared to controls. The microen-
apsulated also showed signiﬁcant activity, reducing the protein
xtravasation at both doses tested, but with better response at dose
f 300 mg/kg with maximum inhibition of 67 ± 3%. For the positive
ontrol the inhibition was 91 ± 2% (Fig. 2).
PCA prevented nociception, cold sensitivity, and neurogenic
dema induced by formalin in rats
MPCA (Fig. 3A, Phase I) produced signiﬁcant antinociceptive
ffects in the ﬁrst phase when compared with the control group.
t the dose of 100 mg/kg, maximum inhibition was  59 ± 2%, while
t the dose of 300 mg/kg, it was 63 ± 3%, and for dexamethasone, it
as 73 ± 2%.
MPCA at doses of 100 and 300 mg/kg signiﬁcantly reduced lick-
ng time in the second phase of the formalin test in rats (Fig. 3B,
hase II). At a dose of 100 mg/kg, maximum inhibition was 72 ± 1%,
t a dose of 300 mg/kg, it was 70 ± 2%, and for dexamethasone, it
as 85 ± 3%.
MPCA caused a reduction in paw edema induced by formalin.
ig. 3C shows the results of paw edema with maximal inhibition of
9 ± 1% for MPCA at the dose of 300 mg/kg, 64 ± 3% at the dose of
00 mg/kg, and 87 ± 2% for dexamethasone.
MPCA (100 and 300 mg/kg) signiﬁcantly attenuated the duration
f cold hypersensitivity after formalin injection. Animals almost did
ot move and raised their paws a few times after acetone applica-
ion. At a dose of 100 mg/kg, maximum inhibition was  55 ± 2%, at a
ose of 300 mg/kg, it was 60 ± 2%, and for dexamethasone, 86 ± 3%.
urthermore, hypersensitive response to cold was <10 s (Fig. 3D).
Open ﬁeld results demonstrated that the orally administered
icrocapsules were not capable of reducing locomotor activity
hen compared with the control group (results not shown).
PCA prevented carrageenan-induced paw edema
An hour after the carrageenan-induced inﬂammation, the con-
rol group continued to show edema, whereas the groups treated
ith microcapsules at doses of 100 and 300 mg/kg showed a signiﬁ-
ant decrease in edema compared to the control group (Fig. 4A) and
his reduction continued after the second, third and fourth hour of
bservation (Fig. 4B–D). Fig. 4 shows paw edema was also inhibited
t all times, and maximal inhibition at the dose of 100 mg/kg was
2 ± 2%, 63 ± 3%, 86 ± 3%, and 77 ± 2%, after 1, 2, 3, and 4 h, respec-
ively. The inhibitions, dose of 300 mg/kg, were 53 ± 2%, 68 ± 3%,Please cite this article in press as: Viscardi, D.Z., et al. Anti-inﬂamma
microencapsulated pulp. Revista Brasileira de Farmacognosia (2016), 
6 ± 2%, and 80 ± 3% after 1, 2, 3, and 4 h, respectively. The animals
reated with dexamethasone, the positive control, showed a signif-
cant reduction at all time points, with inhibitions of 93 ± 7% after
 h and 85 ± 5% after 4 h.of  six animals. *p < 0.001 when compared to the control group. Differences between
groups were analyzed by analysis of variance (two-way ANOVA) followed by the
Bonferroni tests.
MPCA fruits prevented CFA-induced mechanical and cold
hyperalgesia and knee edema
The results of mechanical hyperalgesia assessed by analges-
imeter are shown in Fig. 5. Treatment with CFA and MPCA
demonstrated a signiﬁcant increase in paw withdrawal threshold
after 10 days of treatment when compared with the control group.
Microcapsules of C. adamantium pulp presented an effect against
mechanical hyperalgesia at all days analyzed (Fig. 5A). On the ﬁrst
day, signiﬁcant results were observed after 2 and 3 h of CFA injec-
tion at a dose of 100 mg/kg with maximal inhibition of 61 ± 1% after
2 h and 55 ± 2% after 3 h. On day 9, they demonstrated maximal
inhibition of 86 ± 2% and reduction of edema on day 6 with maximal
inhibition of 87 ± 3% (Fig. 5B). Signiﬁcant differences in mechani-
cal thresholds were observed in the group treated with CFA and
microencapsulated pulp of C. adamantium. These results are very
similar to those of the control group.
Administration of MPCA (100 mg/kg) signiﬁcantly attenuatedtory, and antinociceptive effects of Campomanesia adamantium
http://dx.doi.org/10.1016/j.bjp.2016.09.007
the duration of cold hypersensitivity. The treated group almost
did not move and raised their paws a few times with acetone
application. Furthermore, the hypersensitive response to cold in
the treated group was  <10 s, there was  a signiﬁcant decrease in
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Fig. 6. (A) Effect of microencapsulated pulp of Campomanesia adamantium (MPCA) on cold sensitivity after treatment with microcapsules at the dose of 100 mg/kg and an
injection  of CFA (Freund’s Complete Adjuvant) in the right hind paw. (B) Effect of MPCA on cold sensitivity after treatment with microcapsules on the 10th days after CFA
injection. (C) Effect of MPCA on knee edema at the 10th day after CFA injection. The test was  performed in mice using a micrometer. (D) Effect of MPCA on tail suspension test.
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teconds. Each bar represents the mean ± SEM of six animals. *p < 0.05, **p < 0.01, ***p
y  analysis of variance (one-way ANOVA) followed by the Newman–Keuls test.
ovements when compared with the control (Fig. 6A), and one day
fter CFA injection, the maximum inhibition was 44 ± 2%. There was
 decrease in licking time after 10 days. On the ﬁrst day, licking time
as 6 s and on the last day, it was 4 s, while on the 10th day after
pplying the CFA the maximum inhibition was 62 ± 3% (Fig. 6B).
For knee edema test after 10 days we could see maximum inhi-
ition of 63 ± 1% (Fig. 6C) and for tail suspension test maximum
nhibition was 67 ± 2% (Fig. 6D), when compared with the control
roup.
iscussion
Despite its economic and cultural importance in the Brazilian
errado, there are few clinical trials with the species C. adamantium.
any ethnopharmacological studies have reported pharmacolog-
cal efﬁciency (Souza et al., 2014). Myrtaceae family plants are
istributed throughout the Cerrado region of Brazil and some
pecies have been used to treat pain, inﬂammation and other
iseases. These anti-inﬂammatory properties are attributed to
avonoids and chalcones, present as the main constituents of the
xtract of this plant (Pavan et al., 2009; Ramos et al., 2007; Coutinho
t al., 2009) and fruit pulp. Flavonoids (Coutinho et al., 2008)
re widely distributed among plants and exhibit pharmacological
ffects on the inﬂammatory process.
The present study demonstrated the anti-inﬂammatory and
ntinociceptive analyses of C. adamantium microencapsulated
ulp. Experimental data demonstrated C. adamantium microen-
apsulated pulp inhibited leukocyte migration, inﬂammatory,
eurogenic pain and edema, CFA-induced paw inﬂammation andPlease cite this article in press as: Viscardi, D.Z., et al. Anti-inﬂamma
microencapsulated pulp. Revista Brasileira de Farmacognosia (2016), 
echanic hypersensitivity measurement suggesting their use as a
utraceutical or pharmacological agent.
Previous results from our group have demonstrated that
he hydroalcoholic extract of the fruit peel of C. adamantium1 when compared to the control group. Differences between groups were analyzed
exhibited anti-inﬂammatory and antihypernociceptive effects in
pleurisy and mechanical nociception (Souza et al., 2014). In the
present study, the results have indicated the anti-inﬂammatory
and antinociceptive actions of the microencapsulated pulp C.
adamantium. Experimental data have demonstrated that MPCA
inhibited leukocyte migration, inﬂammatory and neurogenic pain,
and edema, suggesting their use as a nutraceutical or pharmaco-
logical agent. Those ﬁndings corroborate with the popular use of
C. adamantium fruits as anti-inﬂammatory (Ramos et al., 2007).
The anti-inﬂammatory activity of MPCA in acute inﬂammation
was evaluated by induction of a carragenan-induced pleurisy
model. This is a classic test to evaluate this type of inﬂammation
and the formation of a pleural exudate in the cavity is charac-
terized by inﬁltration of polymorphonuclear leukocytes and the
release of several important chemical mediators in the inﬂamma-
tory process (Oliveira et al., 2014). Anti-inﬂammatory drugs, such
as indomethacin and dexamethasone, inhibit leukocyte migration
between 3 and 6 h after carrageenan administration.
Treatment with MPCA 1 h before carrageenan injection was able
to signiﬁcantly decrease the total leukocyte recruitment in the
pleural cavity. This result was  also conﬁrmed by Ferreira et al.
(2013) and Souza et al. (2014).
In the paw edema test, there was  a signiﬁcant decrease in
swelling after 3 h from the time of administration when compared
with the control group, as previously observed (Ferreira et al.,
2013). According to Souza et al., this probably happens because
of a reduction in local vascular permeability. Thus, we concluded
that C. adamantium promotes a reduction in cell leakage, leading to
the consequent reduction of proinﬂammatory mediators.tory, and antinociceptive effects of Campomanesia adamantium
http://dx.doi.org/10.1016/j.bjp.2016.09.007
HPLC analyses of C. adamantium microcapsules have iden-
tiﬁed 2′,4′-dihydroxy-5′-methyl-6′-metoxichalcone as a major
constituent, which corroborates the data of Pascoal et al., the
phytochemical study of ethyl acetate fraction, which led to
 ING ModelB
a de F
t
6
a
c
l
a
m
t
c
i
t
p
c
c
m
s
(
t
s
d
t
t
o
t
p
i
a
d
p
s
t
t
i
n
i
t
e
m
i
p
t
b
p
a
c
p
t
p
n
e
a
E
P
t
t
t
lARTICLEJP-322; No. of Pages 8
D.Z. Viscardi et al. / Revista Brasileir
he isolation and identiﬁcation of the chalcone (2′,4′-dihydroxy-
′-metoxichalcona), which showed promising antiproliferative
ctivity against some of the human tumor cell lines studied.
Some of these compounds and substances of the class of chal-
ones have been described as natural analgesic agents in the
iterature (Raygude et al., 2012) and presented chemopreventive
nd antitumor effects (Rahman, 2012). Ferreira et al. has reported
yricetin as a potential compound responsible for antinocicep-
ive action of C. adamantium extract. Maybe myricetin and other
ompounds found in this species exhibit antihyperalgesic and anti-
nﬂammatory effects.
Phytochemical evaluation has identiﬁed the presence of three
ypes of ﬂavonols, two of ﬂavonones, and two of chalcones, which
resented the highest chromatographic proﬁle of both pulp micro-
apsules. According to Dewick (2005), the increase in chalcone
ontent may  be related to a biosynthetic strategy for the for-
ation of ﬂavonones that could interfere in the production of
econdary metabolites of plants as a defense strategy of these plants
Harbone, 1994). Furthermore, according to Coutinho et al. (2010)
his increase may  be due to the accumulation of ﬂavonoids on the
urface of the leaf as a form of protection from sunlight or as a plant
efense mechanism against insects.
It is known that ﬂavonoids are plant polyphenol compounds
hat present analgesic and anti-inﬂammatory properties by inhibi-
ing enzymes involved in inﬂammation and pain in several parts
f the nervous system (Coutinho et al., 2010). In the inﬂamed
issue, ﬂavonoids are able to inhibit cyclooxygenase, prevent
rostaglandin formation and TNF secretion, which are responsible
n stimulating pain receptors in the brain. Flavonoids also decrease
nalgesic activity by inhibiting nitric oxide synthesis and NO pro-
uction.
We know that the chemistry of natural products appears to be a
romising alternative and has attracted the increasing attention of
cientists to search for new pharmacologically active agents, mainly
o improve the treatment of pain. Therefore, the present investiga-
ion of the administration of MPCA (100 mg/kg per day for 10 days)
s a new approach and has a beneﬁcial effect on the treatment of
europathy because of its multiple effects: anti-inﬂammatory, as
ndicated by the CFA-induced paw edema test, and antinocicep-
ive, as indicated by the CFA-induced cold sensitivity, induced knee
dema, and tail suspension tests.
In this study, we have observed that the microencapsulation
ethod of spray drying has great applicability, being character-
zed as an effective method and one of extreme importance in the
reservation of several nutritional components, protecting against
he most aggressive methods of processing. The maintenance of
ioactive compounds, such as ﬂavonoids in microencapsulated
ulp from C. adamantium, can also be observed in this work.
MPCA has demonstrated anti-inﬂammatory and antihyper-
lgesic activities, probably due to the presence of bioactive
ompounds that interfere with inﬂammatory parameters, sup-
orting the use of this plant part in folk medicine. In addition,
he microcapsules retained the stability of the bioactive com-
ounds, enhancing the development of new products based on
atural products. Additional studies are needed to elucidate the
xact mechanism of action and the compounds responsible for this
ctivity.
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